Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-26 @ 3:11 AM
NCT ID:
NCT00267020
Group ID:
EG000
Title:
Enzastaurin+Gemcitabine
Description:
Enzastaurin: 1200 milligrams (mg) administered orally (as three 400-mg doses) after a meal on Day 1, then 500 mg orally, daily (as five 100-mg tablets) after lunch on Days 2 to 28 in Cycle 1, then 500 mg orally, daily (as five 100-mg tablets) after lunch on Days 1 to 28 in Cycle 2 and later.
Gemcitabine: 1000 milligrams/square meter (mg/m\^2) administered intravenously on Days 1, 8 and 15 of each 28-day cycle.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
49
Serious Number At Risk:
82
Other Number Affected:
80
Other Number At Risk:
82
Study:
NCT00267020
Results Section:
NCT00267020
Adverse Events Module:
NCT00267020